Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peyman Hadji

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 7, 2012
Bisphosphonates: prevention of bone metastases in breast cancerMichael Gnant, Peter Dubsky, Peyman Hadji
Cancer Management and Research|May 10, 2012
Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormonesensitive early breast cancer: a case studyJane Bryce, Martina Bauer, Peyman Hadji
Medizinische Monatsschrift Fur Pharmazeuten|April 29, 2016
[The calcium debate--strong bones at the expense of cardiovascular health?]Alexander Ströhle, Peyman Hadji, Andreas Hahn
Oncology Nursing Forum|May 3, 2011
Aromatase inhibitor-associated bone lossJane Bryce, Martina Bauer, Peyman Hadji
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 17, 2010
Treatment with teriparatide in a patient with pregnancy-associated osteoporosisLars Hellmeyer, Jelena Boekhoff, Peyman Hadji
Patient Preference and Adherence|December 7, 2016
Gender- and age-related treatment compliance in patients with osteoporosis in GermanyPeyman Hadji, Louis Jacob, Karel Kostev
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2017
Prevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany
Louis Jacob, Karel Kostev, Peyman Hadji
Journal of Alzheimer'S Disease : JAD|July 30, 2018
Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in GermanyKarel Kostev, Peyman Hadji, Louis Jacob
Current Medical Research and Opinion|February 6, 2014
Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifeneJean-Yves Reginster, Serge Ferrari, Peyman Hadji
Archives of Osteoporosis|April 23, 2024
Correction: Bone evaluation study-2: update on the epidemiology of osteoporosis in GermanyPeyman Hadji, Elizabeth Esterberg, Dominik Obermüller, et al.
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 7, 2012
Bisphosphonates: prevention of bone metastases in breast cancerMichael Gnant, Peter Dubsky, Peyman Hadji
Cancer Management and Research|May 10, 2012
Managing arthralgia in a postmenopausal woman taking an aromatase inhibitor for hormonesensitive early breast cancer: a case studyJane Bryce, Martina Bauer, Peyman Hadji
Medizinische Monatsschrift Fur Pharmazeuten|April 29, 2016
[The calcium debate--strong bones at the expense of cardiovascular health?]Alexander Ströhle, Peyman Hadji, Andreas Hahn
Oncology Nursing Forum|May 3, 2011
Aromatase inhibitor-associated bone lossJane Bryce, Martina Bauer, Peyman Hadji
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 17, 2010
Treatment with teriparatide in a patient with pregnancy-associated osteoporosisLars Hellmeyer, Jelena Boekhoff, Peyman Hadji
Patient Preference and Adherence|December 7, 2016
Gender- and age-related treatment compliance in patients with osteoporosis in GermanyPeyman Hadji, Louis Jacob, Karel Kostev
International Journal of Clinical Pharmacology and Therapeutics|February 9, 2017
Prevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany
Louis Jacob, Karel Kostev, Peyman Hadji
Journal of Alzheimer'S Disease : JAD|July 30, 2018
Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in GermanyKarel Kostev, Peyman Hadji, Louis Jacob
Current Medical Research and Opinion|February 6, 2014
Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifeneJean-Yves Reginster, Serge Ferrari, Peyman Hadji
Archives of Osteoporosis|April 23, 2024
Correction: Bone evaluation study-2: update on the epidemiology of osteoporosis in GermanyPeyman Hadji, Elizabeth Esterberg, Dominik Obermüller, et al.
Pageof 18